XML 125 R6.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements Of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Income
Noncontrolling Interest [Member]
Balance, beginning of year at Dec. 31, 2016 $ 155,136 $ 0 $ 143,284 $ 11,761 $ 91
Balance, beginning of year, shares at Dec. 31, 2016   1,884      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income attributable to the Company 25,707   25,707    
Dividends (7,073)   (7,073)    
Shares of common stock repurchased and retired (in shares)   (1)      
Shares of common stock repurchased and retired (246)   (246)    
Stock options and stock appreciation rights exercised (in shares)   3      
Stock options and stock appreciation rights exercised 0   0    
Share-based compensation expense 219   219    
Amortization related to postretirement health benefits 6     6  
Accumulated postretirement benefit obligation adjustment 46     46  
Net unrealized gain (loss) on investments 4,132     4,132  
Net income (loss) attributable to noncontrolling interest (6)       (6)
Balance, end of year at Dec. 31, 2017 177,921 $ 0 161,891 15,945 85
Balance, end of year, shares at Dec. 31, 2017   1,886      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income attributable to the Company 21,892   21,892    
Dividends (23,017)   (23,017)    
Shares of common stock repurchased and retired (in shares)   0      
Shares of common stock repurchased and retired (29)   (29)    
Stock options and stock appreciation rights exercised (in shares)   1      
Stock options and stock appreciation rights exercised (1)   (1)    
Share-based compensation expense 327   327    
Cumulative-effect adjustment for adoption of new accounting standards 0   13,627 (13,627)  
Accumulated postretirement benefit obligation adjustment 37     37  
Net unrealized gain (loss) on investments (1,406)     (1,406)  
Subsidiary return of capital (52)       (52)
Net income (loss) attributable to noncontrolling interest (33)       (33)
Balance, end of year at Dec. 31, 2018 175,639 $ 0 174,690 949 0
Balance, end of year, shares at Dec. 31, 2018   1,887      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income attributable to the Company 31,458   31,458    
Dividends (18,131)   (18,131)    
Shares of common stock repurchased and retired (in shares)   0      
Shares of common stock repurchased and retired (19)   (19)    
Stock options and stock appreciation rights exercised (in shares)   2      
Stock options and stock appreciation rights exercised 0   0    
Share-based compensation expense 264   264    
Accumulated postretirement benefit obligation adjustment 0        
Net unrealized gain (loss) on investments 2,151     2,151  
Net income (loss) attributable to noncontrolling interest 0        
Balance, end of year at Dec. 31, 2019 $ 191,362 $ 0 $ 188,262 $ 3,100 $ 0
Balance, end of year, shares at Dec. 31, 2019   1,889